FDA approves vemurafenib (Zelborafa) for metastatic melanoma, spec in pts whose tumors express BRAF V600E. Stand by for our full coverage!
6:40 AM - 17 Aug 2011
0 replies
1 retweet
0 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.